Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 16, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Enters Strategic Partnership Agreement with Genecast Biotechnology to Partner with Biopharma Solutions in China

PARSIPPANY, NJ, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc.’s subsidiary, Interpace BioPharma Inc. (“Interpace”, “Interpace BioPharma” or the “Company”) today announced that...
September 06, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright

PARSIPPANY, NJ, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (“Interpace” or the “Company”) (NASDAQ: IDXG) today announced that the Company will present at the upcoming 21st...
August 13, 2019 08:15 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update

Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and...
August 06, 2019 16:05 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

PARSIPPANY, NJ, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it will report its second quarter 2019 financial results on Tuesday, August...
July 31, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan

In Network Access for More Than 6 Million Members PARSIPPANY, NJ, July 31, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has contracted with Blue...
July 29, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces Contract with Blue Shield of California for ThyGeNEXT® & ThyraMIR®

Four Million Members Gain in-Network Access PARSIPPANY, NJ, July 29, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has entered in to a contract...
July 22, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Announces New Agreement with SelectHealth

Expected to Benefit More than 850,000 Members PARSIPPANY, NJ, July 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has reached an agreement...
July 18, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis

PARSIPPANY, NJ, July 18, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company), announced today that it has executed an agreement with the Helomics...
July 15, 2019 16:10 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners

Conference Call to be Held Tomorrow, Tuesday July 16, 2019 @ 8:30 am ET PARSIPPANY NJ, July 15, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (“Interpace” or the...
June 20, 2019 06:55 ET | Source: Interpace Diagnostics Group, Inc.

Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross

PARSIPPANY NJ, June 20, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that its ThyGeNEXT™ and ThyraMIR® tests for thyroid cancer are now covered by...